Search for: "TEVA PHARMACEUTICALS USA, INC." Results 21 - 40 of 404
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 May 2019, 6:18 am by Elizabeth McCuskey
They can be “subsumed within an already tightly circumscribed legal analysis,” as the court recently explained in the patent-construction context in Teva Pharmaceuticals USA Inc. v. [read post]
16 May 2019, 8:15 am by Robert Schaffer & Joseph Robinson
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
16 May 2019, 8:15 am by Robert Schaffer & Joseph Robinson
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
16 May 2019, 8:15 am by Stone Law, P.C.
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
USA, Inc., 566 F.3d 989, 994(Fed. [read post]
6 May 2019, 7:41 pm by Kurt R. Karst
 As Brian McCormick, Vice President & Chief Regulatory Counsel Teva Pharmaceuticals USA, Inc. explained during the Incentivizing Generic Competition Panel at FDLI’s Annual Conference last week, such changes to bioequivalence requirements “midstream” can throw off the years of planning that goes into large ANDA development programs and may have ripple effects in the development of other ANDA products in the pipeline. [read post]
15 Apr 2019, 9:23 pm by Patent Docs
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc.... [read post]
15 Apr 2019, 6:09 am by Matthew L.M. Fletcher
Teva Pharmaceuticals USA Inc.: Allergan & SRMT Cert Petition Questions presented: Whether the Federal Circuit erred in this case, as it did in Acorda Therapeutics, Inc. v. [read post]
1 Apr 2019, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA, Inc., the Federal Circuit reversed a decision by the U.S. [read post]
5 Mar 2019, 7:28 am by Eric L. Young
District Judge Colleen McMahon ruled on February 27th that a False Claims Act suit brought by two former employees of Teva Pharmaceuticals USA, Inc. will proceed to a trial on the merits. [read post]